| P2093 | author name string | D James Surmeier | |
| | Weixing Shen | |
| | Steven M Graves | |
| P2860 | cites work | A prolyl-isomerase mediates dopamine-dependent plasticity and cocaine motor sensitization | Q24314505 |
| | The physiology, signaling, and pharmacology of dopamine receptors | Q28305030 |
| | Striatal neurones have a specific ability to respond to phasic dopamine release | Q28385866 |
| | Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies | Q28580861 |
| | Pharmacosynthetics: Reimagining the pharmacogenetic approach | Q28709274 |
| | A translational profiling approach for the molecular characterization of CNS cell types | Q29615252 |
| | The self-tuning neuron: synaptic scaling of excitatory synapses | Q29616059 |
| | Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action | Q30453635 |
| | Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines | Q30476609 |
| | Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 |
| | Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors | Q30495714 |
| | RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits | Q30504550 |
| | Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. | Q30567117 |
| | Prolonged dopamine signalling in striatum signals proximity and value of distant rewards | Q30572136 |
| | Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors | Q42517796 |
| | Two-photon optical interrogation of individual dendritic spines with caged dopamine | Q42564039 |
| | Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. | Q42747563 |
| | The pathogenesis of Parkinson's disease: a new hypothesis. | Q42857780 |
| | Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration | Q43085680 |
| | Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons | Q43574475 |
| | Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 |
| | D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons. | Q45153496 |
| | Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease | Q46080337 |
| | Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity. | Q46717148 |
| | Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 |
| | Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. | Q48114419 |
| | Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour | Q48204993 |
| | Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation | Q48383210 |
| | Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes | Q48433708 |
| | Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons | Q48441601 |
| | Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. | Q48545028 |
| | Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats. | Q48597422 |
| | Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo | Q48654037 |
| | Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons. | Q51601659 |
| | The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease | Q60715991 |
| | Concurrent activation of striatal direct and indirect pathways during action initiation. | Q30579307 |
| | Thalamic gating of corticostriatal signaling by cholinergic interneurons. | Q30583147 |
| | Differential excitability and modulation of striatal medium spiny neuron dendrites | Q33382961 |
| | Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia | Q33758221 |
| | Different corticostriatal integration in spiny projection neurons from direct and indirect pathways | Q33944484 |
| | Maladaptive striatal plasticity in L-DOPA-induced dyskinesia | Q34094008 |
| | From reinforcement learning models to psychiatric and neurological disorders | Q34161002 |
| | Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia. | Q34165820 |
| | Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum | Q34180202 |
| | Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 |
| | Serotonin induces long-term depression at corticostriatal synapses | Q35040674 |
| | L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission | Q35424424 |
| | Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 |
| | Endocannabinoid-dopamine interactions in striatal synaptic plasticity | Q35898412 |
| | Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. | Q36128447 |
| | Striatal microcircuitry and movement disorders | Q36203205 |
| | Strain-specific regulation of striatal phenotype in Drd2-eGFP BAC transgenic mice | Q36288401 |
| | Modulation of striatal projection systems by dopamine | Q36367283 |
| | CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling | Q36797226 |
| | A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. | Q36901123 |
| | Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses | Q37048087 |
| | Direct-pathway striatal neurons regulate the retention of decision-making strategies | Q37048139 |
| | Differential innervation of direct- and indirect-pathway striatal projection neurons. | Q37060461 |
| | Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors. | Q37276714 |
| | Control of basal ganglia output by direct and indirect pathway projection neurons. | Q37325384 |
| | Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines | Q37479508 |
| | Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia | Q37674269 |
| | Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement | Q37912711 |
| | Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. | Q38366676 |
| | Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. | Q39426286 |
| | Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Q39801798 |
| | GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats | Q40789803 |
| | Distinct roles for direct and indirect pathway striatal neurons in reinforcement. | Q41894840 |
| | Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels. | Q42099006 |
| | Signals through the striatopallidal indirect pathway stop movements by phasic excitation in the substantia nigra. | Q42437678 |
| | L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. | Q42440010 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| P921 | main subject | Parkinson's disease | Q11085 |
| | dopamine | Q170304 |
| | striatum | Q1319792 |
| P304 | page(s) | 109-117 | |
| P577 | publication date | 2014-07-22 | |
| P1433 | published in | Current Opinion in Neurobiology | Q15763572 |
| P1476 | title | Dopaminergic modulation of striatal networks in health and Parkinson's disease | |
| P478 | volume | 29 | |